Yorito Hattori
Overview
Explore the profile of Yorito Hattori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
823
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kakino Y, Hattori Y, Ogata S, Nakaoku Y, Nishimura K, Iida H, et al.
J Am Heart Assoc
. 2025 Mar;
:e039210.
PMID: 40079311
Background: Our previous preclinical study demonstrated that -targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than -targeted replacement mice with carotid artery stenosis due to neurovascular dysfunction....
2.
Hattori Y, Nakaoku Y, Ogata S, Saito S, Nishimura K, Ihara M
Nutrients
. 2025 Feb;
17(4).
PMID: 40005033
Background/objectives: The current approach to obesity care, which primarily focuses on weight loss, is often insufficient because of the challenges in maintaining long-term results. Therefore, novel, safe, and sustainable medications...
3.
Potential therapeutic effects of SIRT1 targeting APOE4-induced microvascular endothelial dysfunction
Hattori Y, Ihara M
EBioMedicine
. 2025 Feb;
113:105594.
PMID: 39922067
No abstract available.
4.
Noda K, Hattori Y, Nishii T, Horinouchi H, Nakaoku Y, Ogata S, et al.
J Am Heart Assoc
. 2025 Jan;
14(3):e036333.
PMID: 39868517
Background: RING finger protein 213 () p.R4810K is an established risk factor for moyamoya disease and intracranial artery stenosis in East Asian people. Recent evidence suggests its potential association with...
5.
Hattori Y, Imada S, Usui R, Yamamoto A, Nakamura M, Ihara M
J Atheroscler Thromb
. 2025 Jan;
PMID: 39864855
Aim: Branch atheromatous disease (BAD), characterized by the occlusion of perforating branches near the orifice of a parent artery, often develops early neurological deterioration because the mechanisms underlying BAD remain...
6.
Yoshimoto T, Saito S, Omae K, Tanaka K, Kita T, Kitamura K, et al.
EClinicalMedicine
. 2024 Dec;
77:102901.
PMID: 39618942
Background: Adrenomedullin has angiogenic and vasoprotective effects in acute ischemic stroke (AIS). This investigator-initiated trial aimed to evaluate the safety, efficacy, and optimal administration of adrenomedullin in treating AIS. Methods:...
7.
Noda K, Hattori Y, Murata H, Kokubo Y, Higashiyama A, Ihara M
Nutrients
. 2024 Oct;
16(19).
PMID: 39408343
: Equol has protective effects against coronary artery disease and dementia by strongly binding to estrogen receptor beta, whereas the intake of soy isoflavone alone does not always confer such...
8.
Anfray A, Schaeffer S, Hattori Y, Santisteban M, Casey N, Wang G, et al.
Nat Neurosci
. 2024 Sep;
27(11):2138-2151.
PMID: 39294490
Apolipoprotein E4 (ApoE4), the strongest genetic risk factor for sporadic Alzheimer's disease, is also a risk factor for microvascular pathologies leading to cognitive impairment, particularly subcortical white matter injury. These...
9.
Saito S, Hosoki S, Yamaguchi E, Ishiyama H, Abe S, Yoshimoto T, et al.
Neurol Genet
. 2024 Sep;
10(5):e200176.
PMID: 39257469
Objectives: Recent advancements in genome research have revealed not only the importance of variants associated with cerebrovascular diseases but also a notably high frequency of carriers harboring multiple variants, presenting...
10.
Chiba T, Hattori Y, Motooka D, Tanaka T, Ihara M
Microorganisms
. 2024 Aug;
12(8).
PMID: 39203533
When treating anaerobic brain abscesses, healthcare professionals often face the difficulty of identifying the causal pathogens, necessitating empiric therapies with uncertain efficacy. We present the case of a 57-year-old woman...